Volume 25, Issue 11 (2-2019)                   RJMS 2019, 25(11): 108-117 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadeghi Shermeh A, Delbandi A A, Tabarsi P, Mortaz E, Khoshmirsafa M, Bolouri M R, et al . Investigating clinical and laboratory findings in patients with drug-resistant and drug-sensitive tuberculosis in Masih Daneshvari Hospital. RJMS 2019; 25 (11) :108-117
URL: http://rjms.iums.ac.ir/article-1-5387-en.html
Iran University of Medical Sciences, Tehran, Iran , M_shekarabi@yahoo.com
Abstract:   (3490 Views)
Background: Although tuberculosis (TB) is often curable, it remains one of the top 10 major causes of death worldwide. Unfortunately, in recent decades, the emergence of Mycobacterium tuberculosis (Mtb) strains resistant to anti-TB drugs (DR-TB) is one of the most critical factors in the treatment of tuberculosis. Therefore, the present study addresses the epidemiologic factors, laboratory and clinical findings affecting the development of tuberculosis and, in particular, resistant forms of it.
Methods: In this study, laboratory and clinical data were collected from 67 patients with drug-susceptible TB (DS-TB), 20 patients with DR-TB admitted to the Masih Daneshvari hospital and 30 healthy controls during one year (2015-16). The disease was confirmed by an infectious specialist according to clinical history, physical examination, radiological and laboratory findings. TB patients were divided into two groups: DS-TB and DR-TB, based on how they responded to treatment. Statistical analysis was performed using SPSS software.
Results: The incidence of DR-TB is associated with several factors, including history of previous treatment and contact with the TB patient. There were also significant differences between the three groups regarding the rate of erythrocyte sedimentation (ESR), C-reactive protein (CRP) and adenosine deaminase (ADA).
Conclusion: According to the results, it is recommended that in high risk patients (with a history of previous treatment and contact with the TB patient, etc.), treatment should be done with greater accuracy and sensitivity. Also, attention to the differences in the clinical and laboratory findings of two DS and DR-TB groups may help in diagnosis and better treatment of the disease.
Full-Text [PDF 1080 kb]   (1222 Downloads)    
Type of Study: Research | Subject: Immunology

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb